Early drug development presents unique challenges for companies navigating the complexities of clinical programs, regulatory landscapes, and market access. This session will explore key trends impacting the drug development pipeline, strategies for overcoming resource constraints, and the growing role of smaller companies in driving pharmaceutical innovation. Join our panel of industry experts as they discuss practical solutions to harmonize global clinical development, manage geopolitical and regulatory complexities, and successfully scale for market entry. Sponsored by: Cencora